WBIO.LSE WisdomTree BioRevolution UCITS ETF - USD Acc GBP

ETF Healthcare Equity WisdomTree Management Limited London Exchange
- GBX
No recent price
Total assets
3.68M
Expense ratio
0.44%
Dividend yield
-
1-year return
+42.50%
Holdings
84
Since
2021

Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.

What does WBIO.LSE invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (85.2%)
  • Largest sector: Healthcare (89.3%)
  • Largest region: North America (84.8%)
  • Top 3 holdings: 10.5% of the fund

Asset allocation

  • US stocks 85.2%
  • Non-US stocks 13.6%
  • Cash 1.2%

Top holdings

All holdings, sectors and regions

WisdomTree BioRevolution UCITS ETF - USD Acc GBP performance

Sharpe ratio 0.76
This year
+41.09%
1 year
+42.50%
3 years
+20.19%
5 years
0.00%

Volatility 24.5% over 1 year and 25.4% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

WBIO.LSE price

Prices on the chart can differ slightly from the closing prices StockSummer shows.